In vivo data have shown that aberrant Jak1 signaling can play an important role in APL pathogenesis and that the JAK-STAT signaling may be activated by different mechanisms in a mouse model of APL. The gene discussed is SOAT1; the disease is acute promyelocytic leukemia.